Clinical Trial Update: Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of docetaxel and capecitabine in recurrent or persistent ovarian epithelial cancer, fallopian tube cancer, and peritoneal cancer was terminated; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2009-05-18